Login to Your Account


Early Success Reported in hESC Trial for Macular Degeneration

By Nuala Moran
BioWorld International Correspondent

Wednesday, January 25, 2012
LONDON – The first patient in the first human embryonic stem cell (hESC) trial to be held in Europe left Moorfields Eye Hospital in London Monday after being treated for macular degeneration.

To continue reading subscribe now to BioWorld International

Learn More about BioWorld International

Already a subscriber? Sign In or Buy now to activate your subscription


»

BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Privacy Policy | Terms of Use
 
Part of Thompson Media Group LLC

Free Ezine

Sign up for Perspectives FREE e-mail newsletter.

Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.